BRK-B vs NFBK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
NFBK presents a complex profile with a Piotroski F-Score of 4/9, indicating stable but mediocre financial health. While the trailing P/E of 692.50 is an extreme outlier, the Forward P/E of 9.23 and a Price-to-Book ratio of 0.84 suggest the market is pricing in a significant earnings recovery and valuing the company below its asset base. However, current profitability is critically low (ROE 0.11%) and the dividend payout ratio of 2600% is fundamentally unsustainable. The stock is currently trading at a massive premium to its Graham Number ($2.73) and Intrinsic Value ($0.14), indicating that the current price is driven by growth expectations rather than current fundamentals.
Compare Another Pair
Related Comparisons
BRK-B vs NFBK: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Northfield Bancorp, Inc. (NFBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.